High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts |
| |
Authors: | Heidi Wähämaa Hanna Schierbeck Hulda S Hreggvidsdottir Karin Palmblad Anne-Charlotte Aveberger Ulf Andersson Helena Erlandsson Harris |
| |
Affiliation: | (1) Department of Women’s and Children’s Health, Pediatric Rheumatology Research Unit Karolinska Institutet, Astrid Lindgren Children Hospital/Karolinska University Hospital, Stockholm, 17176, Sweden;(2) Department of Medicine, Rheumatology Research Unit Karolinska Institutet, CMM Karolinska University Hospital, Stockholm, 17176, Sweden |
| |
Abstract: | Introduction In addition to its direct proinflammatory activity, extracellular high mobility group box protein 1 (HMGB1) can strongly enhance
the cytokine response evoked by other proinflammatory molecules, such as lipopolysaccharide (LPS), CpG-DNA and IL-1β, through
the formation of complexes. Extracellular HMGB1 is abundant in arthritic joint tissue where it is suggested to promote inflammation
as intra-articular injections of HMGB1 induce synovitis in mice and HMGB1 neutralizing therapy suppresses development of experimental
arthritis. The aim of this study was to determine whether HMGB1 in complex with LPS, interleukin (IL)-1α or IL-1β has enhancing
effects on the production of proinflammatory mediators by rheumatoid arthritis synovial fibroblasts (RASF) and osteoarthritis
synovial fibroblasts (OASF). Furthermore, we examined the toll-like receptor (TLR) 4 and IL-1RI requirement for the cytokine-enhancing
effects of the investigated HMGB1-ligand complexes. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|